- Home
- FUBO vs EBS Comparison
FUBO vs EBS Comparison
Compare FUBO & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FUBO | EBS |
|---|---|---|
| Founded | N/A | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 265.1M | 312.8M |
| IPO Year | 2011 | 2006 |
Fundamental Metrics
Financial Performance| Metric | FUBO | EBS |
|---|---|---|
| Price | $7.90 | $6.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $17.00 | $11.00 |
| AVG Volume (30 Days) | 951.2K | ★ 960.8K |
| Earning Date | 11-06-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 125.83 |
| EPS | ★ N/A | N/A |
| Revenue | $4,271,000.00 | ★ $742,900,000.00 |
| Revenue This Year | $40.22 | N/A |
| Revenue Next Year | $4.71 | $7.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10317.07 | N/A |
| 52 Week Low | $1.02 | $4.36 |
| 52 Week High | $14.54 | $14.06 |
Technical Indicators
Market Signals| Indicator | FUBO | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 33.73 | 42.71 |
| Support Level | $1.06 | $5.50 |
| Resistance Level | $10.69 | $6.60 |
| Average True Range (ATR) | 0.45 | 0.34 |
| MACD | -0.02 | -0.11 |
| Stochastic Oscillator | 3.40 | 15.30 |
Price Performance
Historical ComparisonAbout FUBO fuboTV Inc.
FuboTV Inc is a sports-first, Pay TV replacement product offering subscribers access to tens of thousands of live sporting events annually, alongside news and entertainment content, both live and on demand. Its platform is designed to empower customers to seamlessly access content through streaming devices and on Smart TVs, mobile phones, tablets, and computers. The company offers subscribers a live TV streaming service with the option to purchase incremental features, including additional content or enhanced functionality suited to their preferences. Its subscription packages (including Fubo Essential, Pro, Elite, and others) boast a broad mix of top Nielsen-ranked channels across sports, news, and entertainment. The company operates in a single segment of the streaming business.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.